IHC staining confirmed that the co-treatment showed the most reduced marker of proliferation Ki-67 and enhanced cleaved caspase-3 staining (Fig. 7d, e), arguing a more significant inhibition of tumor cell proliferation and intratumoral cell apoptosis in the xenograft tumors. The gene discussed is MKI67; the disease is neoplasm.